Simplex Trading
PRPH

Simplex Trading’s ProPhase Labs PRPH Stock Holding History

Simplex Trading’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-130
Closed -$5K – 9599
2023
Q3 		$5K Sell
130
-120
-48% -$7.03K ﹤0.01% 7680
2023
Q2 		$18K Buy
250
+30
+14% +$2.44K ﹤0.01% 6889
2023
Q1 		$16K Buy
220
+170
+340% +$13.7K ﹤0.01% 7139
2022
Q4 		$4K Buy
50
+20
+67% +$2.16K ﹤0.01% 8245
2022
Q3 		$3K Sell
30
-80
-73% -$9.31K ﹤0.01% 9139
2022
Q2 		$13K Buy
+110
New +$9.67K ﹤0.01% 8063
2022
Q1 		– Sell
-1,250
Closed -$89K – 11187
2021
Q4 		$89K Sell
1,250
-1,650
-57% -$103K ﹤0.01% 6446
2021
Q3 		$174K Hold
2,900
– – ﹤0.01% 5820
2021
Q2 		$179K Buy
+2,900
New +$163K ﹤0.01% 5862

Other funds holding PRPH

CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Simplex Trading's PRPH Position: Q1 2026 in Review

Simplex Trading sold out of ProPhase Labs (PRPH) in Q1 2026, closing a stake of 7,431 shares — an estimated $3.33K sold.

Simplex Trading first reported a position in PRPH in Q1 2021 and held it in 16 quarters. The position peaked at $33K in Q2 2023. 2 funds tracked by Wall St. Rank hold PRPH as of Q1 2026.

  • Simplex Trading reported no remaining ProPhase Labs position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 7,431 ProPhase Labs shares in Q1 2026, an estimated $3.33K.
  • Simplex Trading first reported a position in ProPhase Labs in Q1 2021 and held it in 16 quarters.
  • Simplex Trading's ProPhase Labs position peaked at $33K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.